He is Chief Scientific Officer and co-founder of InterAx Biotech, where he specializes in the development Gebhard Schertler, he developed methods for kinetic mathematical analysis of GPCR signaling. He also worked on creating novel methods for systems biology using temporal logic specifications while Aurelien Rizk shared that he had always focused on GPCRs but had also worked on other types of receptors Yamina asked if there was ever a consideration to work on targets other than GPCRs, to which Aurelien

Authors Weiming Zhao , Lingling Xi , Guoying Yu , Gaiping Wang , Cuifang Chang Source Contribute to the

He is pioneering the investigation of animal toxins acting on GPCRs, the largest therapeutic target class

He described a significant moment when he confirmed a previously uncertain interaction, underscoring He also explained his strategy for finding a suitable postdoc lab, which involved reaching out to labs He highlighted that he had to regain his confidence after a period of three failed experiments.

He has successfully built numerous global life science, leadership teams, & works closely with both clients

He is the head of the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging Michel Bouvier at Université de Montréal, followed by a Postdoctoral Fellow at Scripps Research in San

Authors Hao Shen, Jie Yuan, Dafeng Tong, Bingchen Chen, Enda Yu, Guanglei Chen, Cheng Peng, Wenjun Chang

Terry Hebert to chat about how he and his team has been adapting to the new reality of working remotely

Steve McCloskey is an Alumni from the first class of Nanoengineering at the University of California, San During his time at UC San Diego Steve worked directly with the founding Chair of the Nanoengineering After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and

Since then, he has been studying the allosteric modulation and activation mechanism of this family of

Authors Jiyeon Yu , Ali Zamani , Jason R Goldsmith , Zienab Etwebi , Chin Nien Lee , Youhai H Chen ,

Authors Peng Kong , Xu Wang , Ya-Kun Gao , Dan-Dan Zhang , Xiao-Fu Huang , Yu Song , Wen-Di Zhang , Rui-Juan Guo , Han Li , Mei Han Tags Breast cancer , Regulator of G protein signaling 5 , Vascular remodeling

Authors Kangjie Shen , Qiangcheng Wang , Lu Wang , Yang Yang , Min Ren , Yanlin Li , Zixu Gao , Shaoluan Zheng , Yiteng Ding , Jiani Ji , Chenlu Wei , Tianyi Zhang , Yu Zhu , Jia Feng , Feng Qin , Yanwen Yang

Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San For the past 30 years, he has been the Director of MD/Ph.D. training program at UCSD and has served as Paul Insel on the web Insel Laboratory Institute of Engineering in Medicine UC San Diego UCSD Profiles

his lab have been interested in the molecular pharmacology of cannabinoids for nearly 10 years and he has published more than 50 studies in the field."

Since then, Brendan worked as a research assistant at the Victor Chang Cardiac Research Institute where he

University of Nottingham and began a part-time PhD in Molecular Pharmacology and Drug Discovery that he

Prior to that, Ben received his Ph.D. from UCSF in 2008, where he worked with David Julius on the structure

Milligan has published more than 550 peer-reviewed articles and his research has been cited more than He was elected to the Fellowship of the Royal Society of Edinburgh in 1998 and to the Fellowship of the

Duman is an Assistant Professor in the Department of Neuroscience at Baylor College of Medicine, where he He trained at the University of California at Berkeley with John Forte and the University of Washington

Authors Han Zhou, Tao Hou, Aijin Shen, Wenyi Yu, Liangliang Zhou, Wenjie Yuan, Wanxian Wang, Yumin Yao

Authors Jijun Chen , Liang Wang , Danhua Ma , He Zhang , Jiayan Fan , Hongyan Gao , Xinyu Xia , Wei Wu , Yuyuan Shi Tags GPCR , GRK6 , OSCC , PKC , miRNA Source Contribute to the GPCR News Coming soon Become

Nick joined the University of Nottingham in 2006, where he is now Associate Professor, establishing a

He later joined the laboratory of eminent biochemical pharmacologist, Dr. Alfred G. research career in the Department of Pharmacology at the University of Michigan Medical School, where he Sunahara moved his laboratory to the Department of Pharmacology at the University of California in San

Sai Prasad Pydi obtained his Ph.D. from the University of Manitoba – Canada, where he was introduced

Authors Jiamin Zhou, Xigan He, Weixing Dai, Qingguo Li, Zhen Xiang, Yixiu Wang, Ti Zhang, Weiqi Xu, Lu

Authors Luna Dillemans , Karen Yu , Alexandra De Zutter , Sam Noppen , Mieke Gouwy , Nele Berghmans ,

& master’s degrees in Neurobiology & Cognitive sciences from the University of South Florida, where he He is interested in working on Li-Fraumeni syndrome and helping patients afflicted with this condition He is also interested in working on Glioma Brain Organoid models." He has received his BSc and MS degree from the Department of Biochemistry and Molecular Biology, University Currently, he is working to elucidate the role of ADGRB1 and ADGRB3 in medulloblastoma (pediatric brain